CTOs on the Move

Portola

www.portola.com

 
Portola Pharmaceuticals is dedicated to developing and commercializing therapies that transform patient lives and advance patient care by changing treatment paradigms in thrombosis and other hematologic diseases. Our two lead assets are Bevyxxa® (betrixaban), and andexanet alfa. In addition, cerdulatinib is our investigational Syk/JAK inhibitor to treat hematologic cancers. These compounds come from our own internal research efforts and represent important advances to address significant unmet needs. We are employing novel strategies that may increase the likelihood of clinical, regulatory and commercial success of our potentially lifesaving therapies.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.portola.com
  • 270 E. Grand Avenue
    South San Francisco, CA USA 94080
  • Phone: 650.246.7000

Executives

Name Title Contact Details

Similar Companies

Suncrest Hospice

Suncrest Care is a company that provides home health and hospice care services with a mission to provide the highest quality of care and customer service to patients, their families, and referring sources.

Wave Life Sciences

WAVE Life Sciences is utilizing its innovative and proprietary synthetic chemistry drug development platform to design, develop and commercialize stereopure nucleic acid therapeutics that precisely target the underlying cause of rare genetic diseases, delivering exceptional treatment options for patients. Given the unique versatility of its chemistry platform, WAVE`s pipeline will span multiple oligonucleotide modalities including antisense, exon-skipping and single-stranded RNAi.

Care/of

Get vitamins and supplements for your health goals and diet, made from the best ingredients, shipped to you each month.

ProCare Health Plan

ProCare Health Plan is a Detroit, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Levin Group

Levin Group is a Owings Mills, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.